Jennison Associates
IRWD icon

Jennison Associates’s Ironwood Pharmaceuticals IRWD Stock Holding History

Jennison Associates’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-71,240
Closed -$686K – 603
2023
Q3 		$686K Buy
+71,240
New +$698K ﹤0.01% 508
2022
Q3 		– Sell
-66,879
Closed -$771K – 633
2022
Q2 		$771K Sell
66,879
-67,397
-50% -$794K ﹤0.01% 544
2022
Q1 		$1.69M Buy
134,276
+8,949
+7% +$103K ﹤0.01% 508
2021
Q4 		$1.46M Sell
125,327
-51,330
-29% -$630K ﹤0.01% 568
2021
Q3 		$2.31M Buy
176,657
+61,034
+53% +$789K ﹤0.01% 523
2021
Q2 		$1.49M Buy
115,623
+9,341
+9% +$107K ﹤0.01% 587
2021
Q1 		$1.19M Sell
106,282
-4,572
-4% -$48.3K ﹤0.01% 600
2020
Q4 		$1.26M Sell
110,854
-80,748
-42% -$884K ﹤0.01% 562
2020
Q3 		$1.72M Buy
+191,602
New +$1.9M ﹤0.01% 500

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Jennison Associates's IRWD Position: Q4 2023 in Review

Jennison Associates sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2023, closing a stake of 71,240 shares — an estimated $686K sold.

Jennison Associates first reported a position in IRWD in Q3 2020 and held it in 9 quarters. The position peaked at $2.31M in Q3 2021. 251 funds tracked by Wall St. Rank hold IRWD as of Q4 2023.

  • Jennison Associates reported no remaining Ironwood Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Jennison Associates sold 71,240 Ironwood Pharmaceuticals shares in Q4 2023, an estimated $686K.
  • Jennison Associates first reported a position in Ironwood Pharmaceuticals in Q3 2020 and held it in 9 quarters.
  • Jennison Associates's Ironwood Pharmaceuticals position peaked at $2.31M in Q3 2021.
  • 251 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2023.

Based on Jennison Associates's 13F filing for Q4 2023, filed 1 Feb 2024.